drugset / Trial / NCT00035282

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED)

NCT00035282

Phase 3 Completed 450 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

A clinical study to determine the efficacy and safety of an investigational medication (MK0869) in the treatment of depression.

Timeline

Start
2001-09
Primary completion
2003-12
Completion
2003-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Aprepitant Other / unclassified